MANNOSE, D-
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 180.0 | -3.2 | 5 | 6 | 110.0 | 1 | 1.0 |
- CAS
- 3458284
- UNII
- PHA4727WTP
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 64 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT01808755 | 2012-01-01 | D Mannose in Recurrent Urinary Tract Infections | Phase 3 | Completed |
| NCT00664352 | 2008-02-01 | Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites | Phase 1/Phase 2 | Completed |
| NCT00520325 | 2007-06-01 | A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia | Phase 1 | Withdrawn |
| NCT00415311 | 2006-12-01 | A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients. | Phase 1 | Terminated |
| NCT00886496 | 2006-11-01 | Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia | Phase 1 | Withdrawn |
| NCT00388999 | 2006-09-01 | Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant | Phase 1 | Completed |